Optimizing outcomes and patient experiences in an inflammatory disease
In this project for a global pharma company, Healthskouts explored opportunities for optimizing treatment outcomes in patients with a chronic immune mediated inflammatory disease. Many patients with this disease have significant unmet needs because treatment response is variable, they are poorly monitored and followed up, and because they have limited access (or are not referred […]
Solving the diagnostic delay of an immune mediated inflammatory disease (IMID)
For a global pharma company, Healthskouts conducted in-depth research to better understand and find opportunities for solving the diagnostic delay pertaining to an immune mediated inflammatory disease (IMID). A significant proportion of patients with this condition have to wait several years, with dibilitating symptoms, before they are accurately diagnosed and effectively treated. Our client asked […]